Skip navigation

Innovation in Life Sciences

25th September 2008


  • Innovation in Science: What Innovative Research is and how it is Produced - the View from the Lab Bench
  • The Regulatory Response to Innovation: Policy Issues for Innovation Compared to Traditional Drugs
  • Industry and Innovation: Challenges for Industry
  • Using the Advanced Therapies Regulations to Facilitate Innovation
  • IP Challenges and Issues with Innovative Products and Therapies - Stem Cells Example
  • EU/US Comparison of Institutional Shifts in Regulators Necessary to Regulate Global Innovation and Lessons from Off-Label Use
  • The Precautionary Principle: its centrality and (mis)-Application in Regulatory Decision-Daking
  • Product Liability: Challenges to Innovation by Civil Liability Claims
  • Regulation and Liability Interplay: US Pre-emption Case Law and European Comparative Analysis
  • Socio-Political Implications: Future Policy-Making and Public Consultations

17.45 to 19.15 - Book Launch of OUP Book, The Law and Regulation of Medicines, edited by Dr Peter Feldschreiber.

This event will be followed by a dinner at The Travellers Club with the speakers and will cost £80 per person.

Please click here for a copy of the programme

This event is kindly sponsored by


BIICL collaboration with German Funder on Collective Redress Project

BIICL has recently worked with the German public body, the Gesellschaft fur internationale Zusammenarbeit (GIZ) on a collective redress project....


Germany - Collective Action Draft Bill

Draft Bill for collective actions...